INS and Hyperinsulinemia: Subcutaneous injection of insulin results in significantly higher levels of circulating insulin in the systemic circulation than does endogenous insulin secretion, thereby possibly amplifying the links between hyperinsulinemia and cancer risk through excessive insulin binding to the IGF-I receptor.